Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology

Annals of Neurology

Volumn 42, Issue 5, 1997, Pages 783-793

  Brück, Wolfgang ^a   Bitsch, Andreas ^a   Kolenda, Herbert ^a   Brück, Yvonne ^a   Stiefel, Michael ^a   Lassmann, Hans ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN EDEMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BIOPSY, NEEDLE; DEMYELINATING DISEASES; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURITIS; PARIETAL LOBE; TIME FACTORS;

EID: 0030780349     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420515     Document Type: Article

References (56)

1. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin: Springer-Verlag, 1983
2. Prineas JW. The neuropathology of multiple sclerosis. In: Koetsier JC, ed. Demyelinating Diseases. Amsterdam: Elsevier Science, 1985:213-257
3. Lucchinetti CF, Brück W, Rodriguez M, et al. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274
4. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334
5. McDonald WI, Barnes D. Lessons from magnetic resonance imaging in multiple sclerosis. Trends Neurosci 1989;12:376-379
6. Goodkin DE, Rudick RA, Ross JS. The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol 1994;51: 505-516
7. McDonald WI. NMR in diagnosis, monitoring treatment and epidemiology of multiple sclerosis. Acta Neurol Scand 1995; 161(suppl 161):52-53
8. Poser S, Scheidt P, Kitze B, et al. Impact of magnetic resonance imaging (MRI) on the epidemiology of MS. Acta Neurol Scand 1991;83:172-175
9. Tas MW, Barkhof F, van Walderveen MAA, et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR 1995;16:259-264
10. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 34:683-688
11. Nesbit GM, Forbes GS, Scheithauer BW, et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180: 467-474
12. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34: 661-669
13. Barnes D, Munro PMG, Youl BD, et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280
14. Estes ML, Rudick RA, Barnett GH, et al. Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging. Arch Neurol 1990;47:1299-1303
15. Brück W, Schmied M, Suchanek G, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994;35: 65-73
16. Brück W, Porada P, Poser S, et al. Monocyte/macrophage dif-ferentiaton in early multiple sclerosis lesions. Ann Neurol 1995;38:788-796
17. Poser S, Lüer W, Bruhn H, et al. Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 1992;86:579-585
18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
19. Gunn C, Richards MK, Linington C. The immune response to myelin proteolipid protein in the Lewis rat: identification of the immunodominant B cell epitope. J Neuroimmunol 1990;27: 155-162
20. Piddlesden SJ, Lassmann H, Zimprich F, et al. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 1993;143:555-564
21. Radzun HJ, Hansmann ML, Heidebrecht HJ, et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest 1991;65:306-315
22. Zwadlo G, Schlegel R, Sorg C. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 1986;137:512-518
23. Bhardwaj RS, Zotz C, Zwadlo-Klarwasser G, et al. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/ macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 1992;22:1891-1897
24. Zwadlo G, Bröcker EB, von Bassewitz DB, et al. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 1985; 134:1487-1492
25. Brück W, Huitinga I, Dijkstra CD. Liposome-mediated monocyte depletion during Wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J Neurosci Res 1996;46:477-484
26. Newcombe J, Hawkins CP, Henderson CL, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991;114:1013-1023
27. Khoury SJ, Guttmann CRG, Orav EJ, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994;44:2120-2124
28. Mammi S, Filippi M, Martinelli V, et al. Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis. Acta Neurol Scand 1996;94:93-96
29. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-766
30. Rovaris M, Barnes D, Woodroofe N, et al. Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J Neurol 1996;243:536-542
31. Kidd D, Thompson AJ, Kendall BE, et al. Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity. J Neurol Neurosurg Psychiatry 1994; 57:1070-1072
32. Rieckmann P, Altenhofen B, Riegel A, et al. Soluble adhesion molecules (sVCAM and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann Neurol 1997;41:326-333
33. Hartung H-P, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-193
34. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
35. Powell T, Sussman JG, Davies-Jones GAB. MR imaging in acute multiple sclerosis: ringlike appearance in plaques suggesting the presence of paramagnetic free radicals. AJNR 1992;13: 1544-1546
36. Kermode AG, Tofts PS, Thompson AJ, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990;40: 229-235
37. Hawkins CP, Munro PMG, MacKenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113:365-378
38. Seeldrayers PA, Syha J, Morrissey SP, et al. Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J Neuroimmunol 1993;46:199-206
39. Namer IJ, Steibel J, Piddlesden SJ, et al. Magnetic resonance imaging of antibody-mediated demyelinating experimental allergic encephalomyelitis. J Neuroimmunol 1994;54:41-50
40. Morrissey SP, Stodal H, Zettl U, et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996;119:239-248
41. Raine CS, Cross AH. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 1989;60:714-725
42. 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476
43. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-1592
44. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391
45. Stewart WA, Alvord EC Jr, Hruby S, et al. Magnetic resonance imaging of experimental allergic encephalomyelitis in primates. Brain 1991;114:1069-1096
46. Teresi LM, Hovda D, Seeley AB, et al. MR imaging of experimental demyelination. AJR Am J Roentgenol 1989;152:1291-1298
47. Loevner LA, Grossman RI, McGowan JC, et al. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR 1995;16:1473-1479
48. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58
49. McDonald WI. The pathological and clinical dynamics of multiple sclerosis. J Neuropathol Exp Neurol 1994;53:338-343
50. Koopmans RA, Li DKB, Oger JJF, et al. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39:959-963
51. Kwon EE, Prineas JW. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:625-636
52. Claudio L, Raine CS, Brosnan CF. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol (Berl) 1995;90:228-238
53. Mehta RC, Pike B, Enzmann DR. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR 1996;17:1051-1055
54. Petrella JR, Grossman RI, McGowan JC, et al. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR 1996;17:1041-1049
55. Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:235-241
56. De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909